Representativeness of Black Patients in Cancer Clinical Trials Sponsored by the National Cancer Institute Compared With Pharmaceutical Companies
AbstractBackground. Many clinical trials supporting new drug applications underrepresent minority patients. Trials conducted by the National Cancer Institute’s